SCHEMBL3683550

SCHEMBL3683550

CCC#CC(N)(CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11428479 0.97
SCHEMBL2263738 0.80
SCHEMBL11426713 0.78 FDPS (0.31)
SCHEMBL11441831 0.74
SCHEMBL13783356 0.73
SCHEMBL3989601 0.73
SCHEMBL5158331 0.73
Hydrochloric Acid SCHEMBL4613815 0.71
SCHEMBL28176102 0.67
SCHEMBL3960849 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0938501-B1 PROCESS FOR THE PURIFICATION OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST FROM RECOMBINANT E. COLI AVENTIS BULK S P A (IT) 2004-07-28 EP claimed
US-20100298504-A1 AMPHIPHILIC POLYMER AND PROCESSES OF FORMING THE SAME AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2010-11-25 US disclosed
WO-2009038544-A1 AMPHIPHILIC POLYMER AND PROCESSES OF FORMING THE SAME AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2009-03-26 WO disclosed
US-4205087-A ANTIARTHRITIC AGENTS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-05-27 US disclosed
US-4201725-A TRISUBSTITUTED METHYL-N-METHYLAMINE, PARKINSON*S DISEASE, ANTISPASMODIC AGENTS LABAZ (FR) 1980-05-06 US disclosed
US-4057644-A PARKINSON'S DISEASE LABAZ (FR) 1977-11-08 US disclosed
US-4048334-A PARKINSON*S DISEASE, NEUROLEPTIC AGENTS LABAZ (FR) 1977-09-13 US disclosed
US-4026925-A PARKINSON*S DISEASE LABAZ (FR) 1977-05-31 US disclosed